Vaccines for TB: Lessons from the Past Translating into Future Potentials

Development of vaccines for infectious diseases has come a long way with recent advancements in adjuvant developments and discovery of new antigens that are capable of eliciting strong immunological responses for sterile eradication of disease. Tuberculosis (TB) that kills nearly 2 million of the po...

Full description

Bibliographic Details
Main Authors: Gee Jun Tye, Min Han Lew, Yee Siew Choong, Theam Soon Lim, Maria Elena Sarmiento, Armando Acosta, Mohd Nor Norazmi
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2015/916780
id doaj-c16fdd9af6ac48dfb6f5c74d14ec15f8
record_format Article
spelling doaj-c16fdd9af6ac48dfb6f5c74d14ec15f82020-11-24T22:50:46ZengHindawi LimitedJournal of Immunology Research2314-88612314-71562015-01-01201510.1155/2015/916780916780Vaccines for TB: Lessons from the Past Translating into Future PotentialsGee Jun Tye0Min Han Lew1Yee Siew Choong2Theam Soon Lim3Maria Elena Sarmiento4Armando Acosta5Mohd Nor Norazmi6Institute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Minden, Penang, MalaysiaInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Minden, Penang, MalaysiaInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Minden, Penang, MalaysiaInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Minden, Penang, MalaysiaSchool of Health Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, MalaysiaInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Minden, Penang, MalaysiaInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Minden, Penang, MalaysiaDevelopment of vaccines for infectious diseases has come a long way with recent advancements in adjuvant developments and discovery of new antigens that are capable of eliciting strong immunological responses for sterile eradication of disease. Tuberculosis (TB) that kills nearly 2 million of the population every year is also one of the highlights of the recent developments. The availability or not of diagnostic methods for infection has implications for the control of the disease by the health systems but is not related to the immune surveillance, a phenomenon derived from the interaction between the bacteria and their host. Here, we will review the immunology of TB and current vaccine candidates for TB. Current strategies of developing new vaccines against TB will also be reviewed in order to further discuss new insights into immunotherapeutic approaches involving adjuvant and antigens combinations that might be of potential for the control of TB.http://dx.doi.org/10.1155/2015/916780
collection DOAJ
language English
format Article
sources DOAJ
author Gee Jun Tye
Min Han Lew
Yee Siew Choong
Theam Soon Lim
Maria Elena Sarmiento
Armando Acosta
Mohd Nor Norazmi
spellingShingle Gee Jun Tye
Min Han Lew
Yee Siew Choong
Theam Soon Lim
Maria Elena Sarmiento
Armando Acosta
Mohd Nor Norazmi
Vaccines for TB: Lessons from the Past Translating into Future Potentials
Journal of Immunology Research
author_facet Gee Jun Tye
Min Han Lew
Yee Siew Choong
Theam Soon Lim
Maria Elena Sarmiento
Armando Acosta
Mohd Nor Norazmi
author_sort Gee Jun Tye
title Vaccines for TB: Lessons from the Past Translating into Future Potentials
title_short Vaccines for TB: Lessons from the Past Translating into Future Potentials
title_full Vaccines for TB: Lessons from the Past Translating into Future Potentials
title_fullStr Vaccines for TB: Lessons from the Past Translating into Future Potentials
title_full_unstemmed Vaccines for TB: Lessons from the Past Translating into Future Potentials
title_sort vaccines for tb: lessons from the past translating into future potentials
publisher Hindawi Limited
series Journal of Immunology Research
issn 2314-8861
2314-7156
publishDate 2015-01-01
description Development of vaccines for infectious diseases has come a long way with recent advancements in adjuvant developments and discovery of new antigens that are capable of eliciting strong immunological responses for sterile eradication of disease. Tuberculosis (TB) that kills nearly 2 million of the population every year is also one of the highlights of the recent developments. The availability or not of diagnostic methods for infection has implications for the control of the disease by the health systems but is not related to the immune surveillance, a phenomenon derived from the interaction between the bacteria and their host. Here, we will review the immunology of TB and current vaccine candidates for TB. Current strategies of developing new vaccines against TB will also be reviewed in order to further discuss new insights into immunotherapeutic approaches involving adjuvant and antigens combinations that might be of potential for the control of TB.
url http://dx.doi.org/10.1155/2015/916780
work_keys_str_mv AT geejuntye vaccinesfortblessonsfromthepasttranslatingintofuturepotentials
AT minhanlew vaccinesfortblessonsfromthepasttranslatingintofuturepotentials
AT yeesiewchoong vaccinesfortblessonsfromthepasttranslatingintofuturepotentials
AT theamsoonlim vaccinesfortblessonsfromthepasttranslatingintofuturepotentials
AT mariaelenasarmiento vaccinesfortblessonsfromthepasttranslatingintofuturepotentials
AT armandoacosta vaccinesfortblessonsfromthepasttranslatingintofuturepotentials
AT mohdnornorazmi vaccinesfortblessonsfromthepasttranslatingintofuturepotentials
_version_ 1725671598392868864